Has John Redmond, MD received payments from drug or device companies?

Yes. Drug and device makers reported $986,939 in general payments to John Redmond, MD across 510 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Redmond, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Redmond, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Redmond, MD

Adult Reconstructive Orthopaedic Surgery · Jacksonville, FLNPI 1407977606

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $692,419 of the $986,939 with a category attached, or 70.2%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 59.1% of the total. Reporting peaked in 2022 at $313,006 and has fallen 58.5% since, to $129,742 in 2025. Among adult reconstructive orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$986,939in general payments, 2019–2025

Across 510 payments — averaging $1935.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$583K
Depuy Synthes Products, Inc.$379K
UOC USA Inc$9K
Stryker$8K
Arthrex$5K
Johnson & Johnson$1K
plus $1K from 8 others

$87,676in research payments, 2019–2025

Across 15 payments — averaging $5845.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$85K
Stryker$3K

What the payments were for

Royalty or licence$220,00022%
Consulting fees$692,41970%
Speaking & faculty fees$4,0000%
Travel & lodging$60,5856%
Food & beverage$9,9341%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	294	$583,169
Depuy Synthes Products, Inc.	133	$379,192
UOC USA Inc	6	$8,850
Stryker	38	$7,885
Arthrex	7	$4,990
Johnson & Johnson	23	$1,411
Encore Medical, LP	1	$761
Radlink, Inc	1	$201
DJO, LLC	1	$149
Biocomposites Inc	1	$121
Medtronic	1	$111
Corelink, LLC	1	$46
Smith+Nephew	2	$31
Pacira Pharmaceuticals Incorporated	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ATTUNE$672,210
ACTIS$585,300
PINNACLE$583,871
Velys$98,264
Kincise$43,728
MAKO$6,627
Resolve$2,304
TRITANIUM$172
RECLAIM$127
Stimulan Rapid Cure$121
CINCHLOCK$121
PlasmaBlade$111
TRIATHLON$103
N/A$101

How this compares

$986,939 in reported general payments places this provider in the 95th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$528,180

Medicare patients

619

Services billed

2,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	43	$864
Diclofenac Sodium	40	$733
Amoxicillin	425	$573
Meloxicam	93	$255
Clindamycin Hcl	84	$129
Cefadroxil	19	$100
Ibuprofen	12	$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Jacksonville

Gavan DuffyJacksonville$543K
Richard HeekinJacksonville$45K
Alisa GeierJacksonville$32K
Richard GrimsleyJacksonville$24K
Joshua RogozinskiJacksonville$10K
Carlos LaverniaMiami$5.4M
Juan SuarezMiami$3.9M
Timothy van de LeurSummerfield$511K
Edward StolarskiSarasota$445K
Andrew NoblePalm Beach Gardens$308K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →